5.75M
-
Financial
Bone Biologics Completes $5.75 Million Round Of Financing
BOSTON, /PRNewswire/ — Bone Biologics (OTCQB: BBLG), an orthobiologic company focused on regenerative medicine, announced today the completion of a $5.75…
Read More »